AI assistant
VERACYTE, INC. — Director's Dealing 2026
Mar 2, 2026
31551_dirs_2026-03-02_f8d23972-7e37-4fd5-a019-61ab8a81b1ee.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VERACYTE, INC. (VCYT)
CIK: 0001384101
Period of Report: 2026-02-26
Reporting Person: Febbo Phillip G. (Chief Scientific & Med Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-02-26 | Common Stock | A | 71806 | — | Acquired | 161292 | Direct |
| 2026-02-26 | Common Stock | F | 24486 | $38.75 | Disposed | 136806 | Direct |
Footnotes
F1: Represents shares of common stock acquired by the Reporting Person upon vesting of certain performance based restricted stock units ("PSUs") on February 26, 2026, upon the certification by the
Board of Directors of the Issuer of the achievement of the performance goals set forth therein. Of such PSUs, 47,863 PSUs vested on February 26, 2026, and the remaining 23,943 will vest on December 2, 2026, subject to the Reporting Person's continuous service to the Issuer through such date.
F2: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of the PSUs and does not represent a sale.